Long-term survival outcomes of duodenal adenocarcinoma: A cohort study with 15-year single-center experience

Figure 1  Screening flow chart of patients with duodenal carcinoma.

Figure 2 Overall survival of duodenal carcinoma patients. A: The median overall survival (OS) of 208 patients with duodenal adenocarcinoma (DA); B: The median disease-free survival (DFS) of 208 patients with DA; C: The median OS of 142 patients with radical operation; D: The median DFS of 142 patients with radical operation; E: The median OS of patients with stage I, II, III, and IV DA; F: Median DFS of patients with stage I, II, III, and IV DA.

Figure 3 Survival of patients with duodenal carcinoma undergoing adjuvant therapy. A: Overall survival (OS) in patients with stage II and stage III duodenal adenocarcinoma (DA) compared with and without adjuvant therapy; B: Disease-free survival (DFS) in patients with stage II and stage III DA compared with and without adjuvant therapy; C: OS in patients with stage II DA compared with and without adjuvant therapy; D: Adjuvant therapy in patients with stage II and stage III DFS with and without treatment; E: OS with and without treatment in patients with stage III; F: DFS with and without treatment in patients with stage III.